Park Ha Biological Technology Co Ltd
PHH0.385USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
11.31MMarket Cap
--P/E TTM
More Details of Park Ha Biological Technology Co Ltd Company
Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.
Park Ha Biological Technology Co Ltd Info
Ticker SymbolPHH
Company namePark Ha Biological Technology Co Ltd
IPO dateDec 27, 2024
CEOZhang (Xiaoqiu)
Number of employees31
Security typeOrdinary Share
Fiscal year-endDec 27
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolPHH
IPO dateDec 27, 2024
CEOZhang (Xiaoqiu)
Company Executives of Park Ha Biological Technology Co Ltd
Name
Name/Position
Position
Shareholding
Change
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2024
FY2023
FY2022
FY2021
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
2.38M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
XTX Markets LLC
0.13%
Two Sigma Investments, LP
0.08%
Ground Swell Capital, LLC
0.06%
Other
36.11%
Shareholders
Shareholders
Proportion
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
XTX Markets LLC
0.13%
Two Sigma Investments, LP
0.08%
Ground Swell Capital, LLC
0.06%
Other
36.11%
Shareholder Types
Shareholders
Proportion
Corporation
63.62%
Venture Capital
0.13%
Investment Advisor
0.08%
Hedge Fund
0.08%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.02%
Other
36.03%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
15
103.15K
0.30%
+40.70K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
+69.00
+0.41%
Jun 30, 2025
Morgan Stanley & Co. LLC
7.03K
0.02%
+7.03K
--
Jun 30, 2025
UBS Financial Services, Inc.
1.47K
0%
+1.47K
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
294.00
0%
+294.00
--
Jun 30, 2025
RBC Capital Markets Wealth Management
19.00
0%
-2.24K
-99.16%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Park Ha Biological Technology Co Ltd?
The top five shareholders of Park Ha Biological Technology Co Ltd are:
Xiaoqiu Holding Ltd holds 19.05M shares, accounting for 56.24% of the total shares.
Changxin International Ltd Partnership holds 2.50M shares, accounting for 7.38% of the total shares.
Geode Capital Management, L.L.C. holds 16.85K shares, accounting for 0.05% of the total shares.
Morgan Stanley & Co. LLC holds 7.03K shares, accounting for 0.02% of the total shares.
UBS Financial Services, Inc. holds 1.47K shares, accounting for 0.00% of the total shares.
Xiaoqiu Holding Ltd holds 19.05M shares, accounting for 56.24% of the total shares.
Changxin International Ltd Partnership holds 2.50M shares, accounting for 7.38% of the total shares.
Geode Capital Management, L.L.C. holds 16.85K shares, accounting for 0.05% of the total shares.
Morgan Stanley & Co. LLC holds 7.03K shares, accounting for 0.02% of the total shares.
UBS Financial Services, Inc. holds 1.47K shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Park Ha Biological Technology Co Ltd?
The top three shareholder types of Park Ha Biological Technology Co Ltd are:
Xiaoqiu Holding Ltd
Changxin International Ltd Partnership
XTX Markets LLC
Xiaoqiu Holding Ltd
Changxin International Ltd Partnership
XTX Markets LLC
How many institutions hold shares of Park Ha Biological Technology Co Ltd (PHH)?
As of 2025Q3, 15 institutions hold shares of Park Ha Biological Technology Co Ltd, with a combined market value of approximately 103.15K, accounting for 0.30% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -81.67%.
What is the biggest source of revenue for Park Ha Biological Technology Co Ltd?
In FY2024, the -- business generated the highest revenue for Park Ha Biological Technology Co Ltd, amounting to -- and accounting for --% of total revenue.
